The University of Chicago Header Logo

Blase Polite

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thompson HM, Omer DM, Lin S, Kim JK, Yuval JB, Veheij FS, Qin LX, Gollub MJ, Wu AJ, Lee M, Patil S, Hezel AF, Marcet JE, Cataldo PA, Polite BN, Herzig DO, Liska D, Oommen S, Friel CM, Ternent CA, Coveler AL, Hunt SR, Garcia-Aguilar J, OPRA Consortium, Verheij FS. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 02; 7(1):e2350903. PMID: 38194231; PMCID: PMC10777257.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    2. Bansal VV, Kim D, Reddy B, Witmer HDD, Dhiman A, Godley FA, Ong CT, Clark S, Ulrich L, Polite B, Shergill A, Malec M, Eng OS, Tun S, Turaga KK. Early Integrated Palliative Care Within a Surgical Oncology Clinic. JAMA Netw Open. 2023 Nov 01; 6(11):e2341928. PMID: 37934497; PMCID: PMC10630898.
      Citations:    Fields:    Translation:Humans
    3. Villamar DM, Polite BN. The Promise of Cancer Health Justice: How Stakeholders and the Community Can Build a Sustained and Equitable System of Cancer Care Through the Lens of Colorectal Cancer Interventions. Cancer J. 2023 Nov-Dec 01; 29(6):338-342. PMID: 37963368.
      Citations:    Fields:    Translation:Humans
    4. Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, Thompson HM, Yuval JB, Kim JK, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Guillem JG, Temple L, Goodman KA, Segal NH, Cercek A, Yaeger R, Nash GM, Widmar M, Wei IH, Pappou EP, Weiser MR, Paty PB, Smith JJ, Wu AJ, Gollub MJ, Saltz LB, Garcia-Aguilar J. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. J Clin Oncol. 2024 Feb 10; 42(5):500-506. PMID: 37883738.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    5. Lee FT, Williams J, Nordgren R, Schwarz JL, Setia N, Roggin K, Polite B, Rangrass G, Liao CY, Millis JM, Keutgen XM. Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases. Am J Surg. 2024 Mar; 229:17-23. PMID: 37802701.
      Citations:    Fields:    Translation:Humans
    6. Morgan RB, Dhiman A, Kim AC, Shergill A, Polite B, Turaga KK, Eng OS. Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases. J Gastrointest Surg. 2023 11; 27(11):2560-2562. PMID: 37308734.
      Citations:    Fields:    Translation:Humans
    7. Peerenboom R, Dhiman A, Witmer HDD, Spurr LF, Polite B, Eng OS, Shergill A, Turaga KK. ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3123-3124. PMID: 36641511.
      Citations:    Fields:    
    8. Dhiman A, Kothary V, Witmer HDD, Bregio C, Sood D, Ong CT, Polite B, Eng OS, Shergill A, Turaga KK. Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery. Ann Surg. 2023 12 01; 278(6):925-931. PMID: 36994703.
      Citations: 1     Fields:    Translation:Humans
    9. Peerenboom R, Dhiman A, Witmer HDD, Spurr LF, Polite B, Eng OS, Shergill A, Turaga KK. PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3114-3122. PMID: 36637640.
      Citations: 2     Fields:    Translation:Humans
    10. Morgan RB, Dhiman A, Sood D, Ong CT, Wu X, Shergill A, Polite B, Turaga KK, Eng OS. Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840. PMID: 36636792.
      Citations:    Fields:    Translation:Humans
    11. Arshad M, Al-Hallaq H, Polite BN, Shogan BD, Hyman N, Liauw SL. ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry. Ann Surg Oncol. 2023 Jan; 30(1):333-334. PMID: 36224512.
      Citations:    Fields:    
    12. Arshad M, Al-Hallaq H, Polite BN, Shogan BD, Hyman N, Liauw SL. Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry. Ann Surg Oncol. 2022 Oct 18. PMID: 36255512.
      Citations:    Fields:    
    13. Dreyer TRF, Hamilton E, Dahl A, Desai B, Kircher S, Polite B, Schroeder C, Fukui M, Hayes-Lattin B, Horvath KA. Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care Model. JCO Oncol Pract. 2022 Nov; 18(11):e1899-e1907. PMID: 36252153.
      Citations:    Fields:    Translation:Humans
    14. Bourbeau BR, Hagerty K, Dickson N, Polite B, Chasky M, Grubbs S. Practice Considerations for Participation in the Enhancing Oncology Model. JCO Oncol Pract. 2022 Nov; 18(11):737-741. PMID: 36252157.
      Citations:    Fields:    Translation:Humans
    15. Van Blarigan EL, Ma C, Ou FS, Bainter TM, Venook AP, Ng K, Niedzwiecki D, Giovannucci E, Lenz HJ, Polite BN, Hochster HS, Goldberg RM, Mayer RJ, Blanke CD, O'Reilly EM, Ciombor KK, Meyerhardt JA. Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405. Int J Cancer. 2023 01 15; 152(2):123-136. PMID: 35904874; PMCID: PMC9691576.
      Citations: 3     Fields:    Translation:Animals
    16. Morgan RB, Yan A, Dhiman A, Shergill A, Polite B, Turaga KK, Eng OS. Survival in Total Preoperative vs. Perioperative Chemotherapy for Patients with Metastatic High-Grade Appendiceal Adenocarcinoma Undergoing CRS/HIPEC. J Gastrointest Surg. 2022 12; 26(12):2591-2594. PMID: 35879590.
      Citations:    Fields:    Translation:Humans
    17. Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB, Guillem JG. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022 08 10; 40(23):2546-2556. PMID: 35483010; PMCID: PMC9362876.
      Citations: 144     Fields:    Translation:HumansCTClinical Trials
    18. Dhiman A, Witmer HDD, Vining CC, Polite B, Turaga KK. ASO Author Reflections: The Utility of Circulating-Tumor DNA in Selecting Patients for Locoregional, Metastases-Directed Therapies in Oligometastatic Foregut Adenocarcinoma. Ann Surg Oncol. 2022 Apr 16. PMID: 35430667.
      Citations:    Fields:    
    19. Shaughnessy E, Johnson DC, Lyss AJ, Parikh RB, Peskin SR, Polite BN, Royalty JA, Sagar B, Smith E, Goh L. Oncology alternative payment models: lessons from commercial insurance. Am J Manag Care. 2022 03; 28(3):98-100. PMID: 35404544; PMCID: PMC10193823.
      Citations:    Fields:    Translation:Humans
    20. McCleary NJ, Zhang S, Ma C, Ou FS, Bainter TM, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis. J Geriatr Oncol. 2022 05; 13(4):469-479. PMID: 35105521; PMCID: PMC9058225.
      Citations: 2     Fields:    Translation:Humans
    21. Dhiman A, Vining CC, Witmer HDD, Sood D, Shergill A, Kindler H, Roggin KK, Posner MC, Ahmed OS, Liauw S, Pitroda S, Liao CY, Karrison T, Weichselbaum R, Polite B, Eng OS, Catenacci DVT, Turaga KK. Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Jan 05. PMID: 34988836; PMCID: PMC8730296.
      Citations:    Fields:    
    22. Vierra M, Dhiman A, Witmer HDD, Ulrich L, Hindi E, Fenton E, Shergill A, Polite B, Eng OS, Turaga KK. Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination. Am J Clin Oncol. 2022 01 01; 45(1):9-13. PMID: 34857698.
      Citations: 2     Fields:    Translation:Humans
    23. Brajcich BC, Benson AB, Gantt G, Eng OS, Marsh RW, Mulcahy MF, Polite BN, Shogan BD, Yang AD, Merkow RP. Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative. J Surg Oncol. 2022 Mar; 125(4):560-563. PMID: 34820843; PMCID: PMC9015333.
      Citations: 4     Fields:    Translation:Humans
    24. Arshad M, Al-Hallaq HA, Polite BN, Hyman N, Liauw S. Intra-Operative Radiation Therapy and Surgical Excision for Locally Recurrent Gastrointestinal Cancers: Initial Results of a Single-Institution Registry. Int J Radiat Oncol Biol Phys. 2021 Nov 01; 111(3S):e28-e29. PMID: 34701081.
      Citations:    
    25. Woofter K, Kennedy EB, Adelson K, Bowman R, Brodie R, Dickson N, Gerber R, Fields KK, Murtaugh C, Polite B, Paschall M, Skelton M, Zoet D, Cox JV. Oncology Medical Home: ASCO and COA Standards. JCO Oncol Pract. 2021 08; 17(8):475-492. PMID: 34255551.
      Citations: 6     Fields:    Translation:Humans
    26. Foster CC, Fleming GF, Karrison TG, Liao CY, Desai AV, Moroney JW, Ratain MJ, Nanda R, Polite BN, Hahn OM, O'Donnell PH, Vokes EE, Kindler HL, Hseu R, Janisch LA, Dai J, Hoffman MD, Weichselbaum RR, Pitroda SP, Chmura SJ, Luke JJ. Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors. Clin Cancer Res. 2021 10 15; 27(20):5510-5518. PMID: 34168049.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    27. Carnahan LR, Jones L, Brewer KC, Watts EA, Peterson CE, Ferrans CE, Cipriano-Steffens T, Polite B, Maker AV, Chowdhery R, Rauscher GH, Molina Y. Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting. J Cancer Educ. 2021 06; 36(3):567-575. PMID: 31838729; PMCID: PMC7293559.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    28. Polite B, D Tucker-Seeley R, Winkfield KM, Hicks-Courant K. Health Equity for Black Americans: The Past Cannot Be Prologue. JCO Oncol Pract. 2021 05; 17(5):252-254. PMID: 33974835.
      Citations: 1     Fields:    Translation:Humans
    29. Jones LA, Brewer KC, Carnahan LR, Parsons JA, Polite BN, Ferrans CE, Warnecke RB, Rauscher GH. Health Insurance Status as a Predictor of Mode of Colon Cancer Detection but Not Stage at Diagnosis: Implications for Early Detection. Public Health Rep. 2022 May-Jun; 137(3):479-487. PMID: 33789522; PMCID: PMC9109539.
      Citations:    Fields:    Translation:Humans
    30. Cipriano-Steffens T, Cursio JF, Hlubocky F, Sumner M, Garnigan-Peters D, Powell J, Arndt N, Phillips L, Lassiter RH, Gilliam M, Petty LE, Pastor RSO, Malec M, Fitchett G, Polite B. Improving End of Life Cancer Outcomes Through Development and Implementation of a Spiritual Care Advocate Program. Am J Hosp Palliat Care. 2021 Dec; 38(12):1441-1450. PMID: 33663241.
      Citations:    Fields:    Translation:Humans
    31. Dreyer T, Wilfong LS, Patel K, Gamble B, Polite BN. Oncology Care Model: A Herculean Effort With Fixable Fatal Flaws. JCO Oncol Pract. 2021 04; 17(4):173-176. PMID: 33539172.
      Citations: 1     Fields:    
    32. Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN, Liao CY, Eng OS, Catenacci DVT, Turaga KK. Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy. Ann Surg Oncol. 2021 Aug; 28(8):4433-4443. PMID: 33420565.
      Citations: 4     Fields:    Translation:Humans
    33. Polite BN, Ratain MJ, Lichter AS. Oncology's "Hockey Stick" Moment for the Cost of Cancer Drugs-The Climate Is About to Change. JAMA Oncol. 2021 01 01; 7(1):25-26. PMID: 33001134.
      Citations: 5     Fields:    Translation:Humans
    34. Catenacci DVT, Moya S, Lomnicki S, Chase LM, Peterson BF, Reizine N, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Hogarth DK, Eng OS, Turaga K, Roggin K, Posner MC, Chang P, Narula S, Rampurwala M, Ji Y, Karrison T, Liao CY, Polite BN, Kindler HL. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325. PMID: 33234578; PMCID: PMC7858231.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    35. Van Blarigan EL, Zhang S, Ou FS, Venlo A, Ng K, Atreya C, Van Loon K, Niedzwiecki D, Giovannucci E, Wolfe EG, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. JAMA Netw Open. 2020 10 01; 3(10):e2023500. PMID: 33125497; PMCID: PMC7599454.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    36. Cipriano-Steffens TM, Carilli T, Hlubocky F, Quinn M, Fitchett G, Polite B. "Let Go, Let God": A Qualitative Study Exploring Cancer Patients' Spirituality and Its Place in the Medical Setting. J Relig Health. 2020 Oct; 59(5):2341-2363. PMID: 31705446.
      Citations: 3     Fields:    Translation:Humans
    37. Berger Y, Schuitevoerder D, Vining CC, Alpert L, Fenton E, Hindi E, Liao CY, Shergill A, Catenacci DVT, Polite BN, Eng OS, Turaga KK. Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma. Ann Surg Oncol. 2021 Mar; 28(3):1777-1785. PMID: 32892267.
      Citations: 2     Fields:    Translation:Humans
    38. Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2021 02; 5(1). PMID: 33426464; PMCID: PMC7785047.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    39. Major A, Polite BN. Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will. Cancer J. 2020 Jul/Aug; 26(4):304-310. PMID: 32732673; PMCID: PMC9040521.
      Citations:    Fields:    Translation:Humans
    40. Vaghaiwalla T, Ruhle B, Memeh K, Angelos P, Kaplan E, Liao CY, Polite B, Keutgen X. Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategies. Surgery. 2021 01; 169(1):162-167. PMID: 32446596.
      Citations: 3     Fields:    Translation:Humans
    41. Ibraheem AF, Giurcanu M, Sowunmi AC, Awolude O, Habeebu M, Popoola A, Sanni F, Agaga LA, Olopade O, Polite BN. Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria. JCO Glob Oncol. 2020 04; 6:560-568. PMID: 32255716; PMCID: PMC7193769.
      Citations: 1     Fields:    Translation:Humans
    42. Guercio BJ, Zhang S, Venook AP, Ou FS, Niedzwiecki D, Lenz HJ, Innocenti F, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA, Hochster HS. Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Jun; 4(3):pkaa024. PMID: 33134818; PMCID: PMC7590517.
      Citations: 5     Fields:    
    43. Brewer KC, Peacock NR, Ferrans CE, Campbell RT, Polite B, Carnahan L, Jones LA, Rauscher GH. Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon Cancer. J Womens Health (Larchmt). 2020 09; 29(9):1192-1202. PMID: 32096681; PMCID: PMC7520915.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    44. Catenacci DVT, Chase L, Lomnicki S, Karrison T, de Wilton Marsh R, Rampurwala MM, Narula S, Alpert L, Setia N, Xiao SY, Hart J, Siddiqui UD, Peterson B, Moore K, Kipping-Johnson K, Markevicius U, Gordon B, Allen K, Racette C, Maron SB, Liao CY, Polite BN, Kindler HL, Turaga K, Prachand VN, Roggin KK, Ferguson MK, Posner MC. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290. PMID: 32058557.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    45. Uppal A, Smieliauskas F, Sharma MR, Maron SB, Polite BN, Posner MC, Turaga K. Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer. 2020 01 15; 126(2):281-292. PMID: 31639217.
      Citations: 3     Fields:    Translation:Humans
    46. Brown JC, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Denlinger CS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance). JNCI Cancer Spectr. 2020 Feb; 4(1):pkz078. PMID: 32259016; PMCID: PMC7043296.
      Citations: 14     Fields:    
    47. Joshi SS, Catenacci DVT, Karrison TG, Peterson JD, Zalupski MM, Sehdev A, Wade J, Sadiq A, Picozzi VJ, Amico A, Marsh R, Kozloff MF, Polite BN, Kindler HL, Sharma MR. Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing. Clin Cancer Res. 2020 01 01; 26(1):18-24. PMID: 31558477; PMCID: PMC6942629.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    48. Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K, Ng K, Van Blarigan E, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. J Clin Oncol. 2019 10 10; 37(29):2620-2631. PMID: 31408415; PMCID: PMC6900834.
      Citations: 27     Fields:    Translation:Humans
    49. Kircher SM, Royce TJ, Upadhyay D, Polite BN. Opaque Results of Federal Price Transparency Rules and State-Based Alternatives. J Oncol Pract. 2019 09; 15(9):463-464. PMID: 31403893.
      Citations:    Fields:    Translation:HumansPHPublic Health
    50. Polite BN, Gluck AR, Brawley OW. Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer. JAMA. 2019 May 07; 321(17):1663-1664. PMID: 30958509.
      Citations: 8     Fields:    Translation:Humans
    51. Polite BN, Seid JE, Freeman M, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Schilsky RL. State of Cancer Care in America: Reflections on an Inaugural Year. J Oncol Pract. 2019 04; 15(4):163-165. PMID: 30856037.
      Citations:    Fields:    Translation:Humans
    52. Polite BN, Cipriano-Steffens TM, Liao C, Miller EL, Arndt NL, Hahn EA. Investigation of a multimedia, computer-based approach to improve knowledge, attitudes, self-efficacy, and receptivity to cancer clinical trials among newly diagnosed patients with diverse health literacy skills. Cancer. 2019 06 15; 125(12):2066-2075. PMID: 30811591.
      Citations: 5     Fields:    Translation:Humans
    53. Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK. Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. JAMA Oncol. 2019 02 01; 5(2):236-242. PMID: 30489611; PMCID: PMC6440196.
      Citations: 22     Fields:    Translation:Humans
    54. Sharma MR, Joshi SS, Karrison TG, Allen K, Suh G, Marsh R, Kozloff MF, Polite BN, Catenacci DVT, Kindler HL. A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636. PMID: 30645764.
      Citations: 16     Fields:    Translation:Humans
    55. Zafar SY, Polite BN, McClellan M. Engaging Patients in Value-Based Cancer Care: A Missed Opportunity. JAMA Oncol. 2018 11 01; 4(11):1479-1480. PMID: 30073281.
      Citations:    Fields:    Translation:Humans
    56. Dahdaleh FS, Sherman SK, Poli EC, Vigneswaran J, Polite BN, Sharma MR, Catenacci DV, Maron SB, Turaga KK. Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial. Surgery. 2018 12; 164(6):1223-1229. PMID: 30297240.
      Citations: 14     Fields:    Translation:Humans
    57. Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J, Timing of Rectal Cancer Response to Chemoradiation Consortium. Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial. Dis Colon Rectum. 2018 Oct; 61(10):1146-1155. PMID: 30192323; PMCID: PMC6130918.
      Citations: 50     Fields:    Translation:HumansCTClinical Trials
    58. Polite BN, Seid JE, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Grubbs SS, Kamin DY, Schilsky RL. A New Look at the State of Cancer Care in America. J Oncol Pract. 2018 07; 14(7):397-399. PMID: 29906212.
      Citations:    Fields:    Translation:Humans
    59. Kirkwood MK, Hanley A, Bruinooge SS, Garrett-Mayer E, Levit LA, Schenkel C, Seid JE, Polite BN, Schilsky RL. The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey. J Oncol Pract. 2018 07; 14(7):e412-e420. PMID: 29906211.
      Citations: 50     Fields:    Translation:Humans
    60. Sehdev A, Karrison T, Zha Y, Janisch L, Turcich M, Cohen EEW, Maitland M, Polite BN, Gajewski TF, Salgia R, Pinto N, Bissonnette MB, Fleming GF, Ratain MJ, Sharma MR. A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2018 08; 82(2):309-317. PMID: 29948021; PMCID: PMC6739841.
      Citations: 10     Fields:    Translation:HumansCells
    61. Wellmann R, Borden BA, Danahey K, Nanda R, Polite BN, Stadler WM, Ratain MJ, O'Donnell PH. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology. Cancer. 2018 07 15; 124(14):3052-3065. PMID: 29742281; PMCID: PMC6354920.
      Citations: 7     Fields:    Translation:Humans
    62. Ward JC, Levit LA, Page RD, Hennessy JE, Cox JV, Kamin DY, Bruinooge SS, Shih YT, Polite BN. Impact on Oncology Practices of Including Drug Costs in Bundled Payments. J Oncol Pract. 2018 05; 14(5):e259-e268. PMID: 29648923.
      Citations: 1     Fields:    Translation:Humans
    63. Polite BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, Cheng Y, Brewer KC, Rauscher GH, Fitchett GA. Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations. Cancer. 2018 06 15; 124(12):2578-2587. PMID: 29579340.
      Citations: 2     Fields:    Translation:Humans
    64. Bestvina CM, Wroblewski KE, Daly B, Beach B, Chow S, Hantel A, Malec M, Huber MT, Polite BN. A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning. J Palliat Med. 2018 06; 21(6):846-849. PMID: 29649399.
      Citations: 3     Fields:    Translation:Humans
    65. Polite BN. The Road From Theory to Reality: Illuminating the Complexity of Prospective Cancer Bundles. J Oncol Pract. 2018 02; 14(2):59-61. PMID: 29346022.
      Citations:    Fields:    Translation:Humans
    66. Mason C, Ellis PG, Lokay K, Barry A, Dickson N, Page R, Polite B, Salgia R, Savin M, Shamah C, Socinski MA. Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting. J Clin Pathw. 2018 Jan-Feb; 4(1):49-54. PMID: 31453358; PMCID: PMC6709712.
      Citations: 9     
    67. Ibraheem A, Polite B. Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes. Cancer. 2017 12 15; 123(24):4752-4756. PMID: 29072791.
      Citations: 12     Fields:    Translation:Humans
    68. de W Marsh R, Talamonti MS, Baker MS, Posner M, Roggin K, Matthews J, Catenacci D, Kozloff M, Polite B, Britto M, Wang C, Kindler H. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362. PMID: 29044544; PMCID: PMC5890423.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    69. Polite BN. Blase Polite on How Disparities Research Must Move Into an Era of Action. Oncology (Williston Park). 2017 10 15; 31(10):709-10, 717. PMID: 29083463.
      Citations: 1     Fields:    Translation:Humans
    70. Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study. Ann Epidemiol. 2017 11; 27(11):731-738.e1. PMID: 29173578; PMCID: PMC5728690.
      Citations: 20     Fields:    Translation:Humans
    71. Pectasides E, Stachler MD, Derks S, Liu Y, Maron S, Islam M, Alpert L, Kwak H, Kindler H, Polite B, Sharma MR, Allen K, O'Day E, Lomnicki S, Maranto M, Kanteti R, Fitzpatrick C, Weber C, Setia N, Xiao SY, Hart J, Nagy RJ, Kim KM, Choi MG, Min BH, Nason KS, O'Keefe L, Watanabe M, Baba H, Lanman R, Agoston AT, Oh DJ, Dunford A, Thorner AR, Ducar MD, Wollison BM, Coleman HA, Ji Y, Posner MC, Roggin K, Turaga K, Chang P, Hogarth K, Siddiqui U, Gelrud A, Ha G, Freeman SS, Rhoades J, Reed S, Gydush G, Rotem D, Davison J, Imamura Y, Adalsteinsson V, Lee J, Bass AJ, Catenacci DV. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48. PMID: 28978556; PMCID: PMC5894850.
      Citations: 144     Fields:    Translation:Humans
    72. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin. 2017 09; 67(5):353-361. PMID: 28738442.
      Citations: 31     Fields:    Translation:Humans
    73. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. Cancer Res. 2017 09 01; 77(17):4548-4555. PMID: 28739629.
      Citations: 33     Fields:    Translation:Humans
    74. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol. 2017 09 10; 35(26):3075-3082. PMID: 28737975.
      Citations: 30     Fields:    Translation:Humans
    75. Polite B, Walradt J. Pursuing Value in Cancer Care: A Model in Progress. J Oncol Pract. 2017 07; 13(7):407-409. PMID: 28650744.
      Citations:    Fields:    Translation:Humans
    76. Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB, Mulkerin DL, Mayer RJ, Blanke C. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401. PMID: 28632865; PMCID: PMC5545896.
      Citations: 382     Fields:    Translation:Humans
    77. O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869. PMID: 28398598; PMCID: PMC5636653.
      Citations: 32     Fields:    Translation:Humans
    78. Bestvina CM, Polite BN. Implementation of Advance Care Planning in Oncology: A Review of the Literature. J Oncol Pract. 2017 10; 13(10):657-662. PMID: 28586259.
      Citations: 27     Fields:    Translation:Humans
    79. Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK. Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer. Lancet Oncol. 2017 06; 18(6):711-712. PMID: 28593843.
      Citations: 12     Fields:    Translation:Humans
    80. Sharma MR, Auman JT, Patel NM, Grilley-Olson JE, Zhao X, Moschos SJ, Parker JS, Yin X, Hayward MC, Polite BN, Marangon E, Posocco B, Toffoli G, Hayes DN, Innocenti F. Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1. JCO Precis Oncol. 2017; 2017. PMID: 30009279; PMCID: PMC6042871.
      Citations: 2     Fields:    
    81. Nabhan A, Polite BN. Dynamic Equilibrium. J Oncol Pract. 2017 06; 13(6):345-347. PMID: 28414556.
      Citations:    Fields:    
    82. Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 04; 18(4):446-453. PMID: 28223062; PMCID: PMC5809128.
      Citations: 155     Fields:    Translation:HumansCTClinical Trials
    83. Naylor K, Fritz C, Polite B, Kim K. Evaluating screening colonoscopy quality in an uninsured urban population following patient navigation. Prev Med Rep. 2017 Mar; 5:194-199. PMID: 28070476; PMCID: PMC5219647.
      Citations: 2     
    84. Polite BN, Kamin DY, Grubbs SS. Reply to P.B. Bach. J Clin Oncol. 2016 12 20; 34(36):4448-4449. PMID: 27998228.
      Citations:    Fields:    
    85. Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN. No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911. PMID: 27601514; PMCID: PMC5063186.
      Citations: 8     Fields:    Translation:Humans
    86. Toffoli G, Sharma MR, Marangon E, Posocco B, Gray E, Mai Q, Buonadonna A, Polite BN, Miolo G, Tabaro G, Innocenti F. Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Feb 15; 23(4):918-924. PMID: 27507617; PMCID: PMC6777349.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    87. Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34. PMID: 27247218.
      Citations: 212     Fields:    Translation:Humans
    88. Polite B, Ward JC, Cox JV, Morton RF, Hennessy J, Page R, Conti RM. A Pathway Through the Bundle Jungle. J Oncol Pract. 2016 06; 12(6):504-9. PMID: 27173604.
      Citations: 6     Fields:    Translation:Humans
    89. Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert S. An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population. J Racial Ethn Health Disparities. 2017 04; 4(2):140-148. PMID: 26983622.
      Citations: 2     Fields:    Translation:Humans
    90. Polite BN, Page RD, Nabhan C. Oncology Pathways-Preventing a Good Idea From Going Bad. JAMA Oncol. 2016 Mar; 2(3):297-8. PMID: 26847876.
      Citations: 3     Fields:    Translation:Humans
    91. Lee AM, Shi Q, Alberts SR, Sargent DJ, Sinicrope FA, Berenberg JL, Grothey A, Polite B, Chan E, Gill S, Kahlenberg MS, Nair SG, Shields AF, Goldberg RM, Diasio RB. Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance). Pharmacogenet Genomics. 2016 Mar; 26(3):133-7. PMID: 26658227; PMCID: PMC4738010.
      Citations: 16     Fields:    Translation:Humans
    92. O'Donnell PH, Karovic S, Karrison TG, Janisch L, Levine MR, Harris PJ, Polite BN, Cohen EE, Fleming GF, Ratain MJ, Maitland ML. Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide. Clin Cancer Res. 2015 Nov 15; 21(22):5092-9. PMID: 26199386; PMCID: PMC4677671.
      Citations: 1     Fields:    Translation:Humans
    93. Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K, Timing of Rectal Cancer Response to Chemoradiation Consortium. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015 Aug; 16(8):957-66. PMID: 26187751; PMCID: PMC4670237.
      Citations: 226     Fields:    Translation:HumansCTClinical Trials
    94. Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10; 33(23):2563-77. PMID: 26101248; PMCID: PMC5015427.
      Citations: 296     Fields:    Translation:Humans
    95. Polite B, Ward JC, Cox JV, Morton RF, Hennessy J, Page R, Conti RM. Reply to M. Thompson et Al. J Oncol Pract. 2015 May; 11(3):263-4. PMID: 25736384.
      Citations:    Fields:    Translation:Humans
    96. Polite BN, Miller HD. Medicare innovation center oncology care model: a toe in the water when a plunge is needed. J Oncol Pract. 2015 Mar; 11(2):117-9. PMID: 25690595.
      Citations: 7     Fields:    Translation:Humans
    97. Polite BN. States as the laboratory for democracy: is anybody paying attention, and does anybody care? J Clin Oncol. 2015 Mar 10; 33(8):815-6. PMID: 25605832.
      Citations: 2     Fields:    Translation:Humans
    98. Polite B, Conti RM, Ward JC. Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist. Am Soc Clin Oncol Educ Book. 2015; e75-80. PMID: 25993241; PMCID: PMC4594838.
      Citations: 12     Fields:    Translation:Humans
    99. Sehdev A, Shih YC, Vekhter B, Bissonnette MB, Olopade OI, Polite BN. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer. 2015 Apr 01; 121(7):1071-8. PMID: 25424411; PMCID: PMC4867231.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    100. Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT. American Society of Clinical Oncology policy statement on medicaid reform. J Clin Oncol. 2014 Dec 20; 32(36):4162-7. PMID: 25403206; PMCID: PMC4879717.
      Citations: 10     Fields:    Translation:Humans
    101. Polite BN, Ward JC, Cox JV, Morton RF, Hennessy J, Page RD, Conti RM. Payment for oncolytics in the United States: a history of buy and bill and proposals for reform. J Oncol Pract. 2014 Nov; 10(6):357-62. PMID: 25398955; PMCID: PMC4223709.
      Citations: 9     Fields:    Translation:Humans
    102. Grubbs SS, Polite BN, Carney J, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED. Eliminating racial disparities in colorectal cancer in the real world: it took a village. Del Med J. 2014 Oct; 86(10):301-5. PMID: 25647858.
      Citations: 3     Fields:    
    103. Sehdev A, Shih YC, Huo D, Vekhter B, Lyttle C, Polite B. The role of statins for primary prevention in non-elderly colorectal cancer patients. Anticancer Res. 2014 Sep; 34(9):5043-50. PMID: 25202089.
      Citations: 9     Fields:    Translation:Humans
    104. Song S, Hong JC, Minsky BD, Chang DT, Polite BN, Liauw SL, Tonlaar N. Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race. Am J Clin Oncol. 2014 Apr; 37(2):122-5. PMID: 23211225.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    105. Salgia R, Patel P, Bothos J, Yu W, Eppler S, Hegde P, Bai S, Kaur S, Nijem I, Catenacci DV, Peterson A, Ratain MJ, Polite B, Mehnert JM, Moss RA. Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies. Clin Cancer Res. 2014 Mar 15; 20(6):1666-75. PMID: 24493831.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    106. Zhang SQ, Polite BN. Achieving a deeper understanding of the implemented provisions of the Affordable Care Act. Am Soc Clin Oncol Educ Book. 2014; e472-7. PMID: 24857142.
      Citations: 5     Fields:    Translation:Humans
    107. Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W. The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. J Am Geriatr Soc. 2013 Nov; 61(11):2043-4. PMID: 24219208.
      Citations: 6     Fields:    Translation:Humans
    108. Jagsi R, Chiang A, Polite BN, Medeiros BC, McNiff K, Abernethy AP, Zon R, Loehrer PJ. Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes. J Oncol Pract. 2013 Nov; 9(6):e290-7. PMID: 23943890.
      Citations: 13     Fields:    Translation:Humans
    109. Bhatta SS, Hou N, Moton ZN, Polite BN, Fleming GF, Olopade OI, Huo D, Hong S. Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer. Springerplus. 2013; 2:356. PMID: 23961419; PMCID: PMC3736077.
      Citations: 12     
    110. Geynisman DM, Zha Y, Kunnavakkam R, Aklilu M, Catenacci DV, Polite BN, Rosenbaum C, Namakydoust A, Karrison T, Gajewski TF, Kindler HL. A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma. J Immunother Cancer. 2013; 1:8. PMID: 24829746; PMCID: PMC4019890.
      Citations: 20     Fields:    
    111. Grubbs SS, Polite BN, Carney J, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013 Jun 01; 31(16):1928-30. PMID: 23589553; PMCID: PMC3661932.
      Citations: 78     Fields:    Translation:Humans
    112. Cipriano TM, Polite BN. Achieving health equity in colorectal cancer: a call to action. Am Soc Clin Oncol Educ Book. 2013; 169-73. PMID: 23714491.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    113. de Souza JA, Polite B, Perkins M, Meropol NJ, Ratain MJ, Newcomer LN, Alexander GC. Unsupported off-label chemotherapy in metastatic colon cancer. BMC Health Serv Res. 2012 Dec 29; 12:481. PMID: 23272659; PMCID: PMC3544564.
      Citations: 4     Fields:    Translation:Humans
    114. Naylor K, Ward J, Polite BN. Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med. 2012 Aug; 27(8):1033-46. PMID: 22798214; PMCID: PMC3403155.
      Citations: 76     Fields:    Translation:Humans
    115. Conti RM, Rosenthal MB, Polite BN, Bach PB, Shih YC. Infused chemotherapy use in the elderly after patent expiration. J Oncol Pract. 2012 May; 8(3 Suppl):e18s-23s. PMID: 22942829; PMCID: PMC3348600.
      Citations: 3     Fields:    
    116. Conti RM, Rosenthal MB, Polite BN, Bach PB, Shih YC. Infused chemotherapy use in the elderly after patent expiration. Am J Manag Care. 2012 May 01; 18(5):e173-8. PMID: 22694111.
      Citations: 3     Fields:    Translation:Humans
    117. Finn RS, Kang YK, Mulcahy M, Polite BN, Lim HY, Walters I, Baudelet C, Manekas D, Park JW. Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012 Apr 01; 18(7):2090-8. PMID: 22238246.
      Citations: 59     Fields:    Translation:HumansCTClinical Trials
    118. Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling RV, Olugbile S, Polite BN, Olopade OI. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res. 2012 Jan 15; 18(2):350-9. PMID: 22114137; PMCID: PMC3272273.
      Citations: 39     Fields:    Translation:Humans
    119. Polite BN, Sylvester BE, Olopade OI. Race and subset analyses in clinical trials: time to get serious about data integration. J Natl Cancer Inst. 2011 Oct 19; 103(20):1486-8. PMID: 21997133; PMCID: PMC3196483.
      Citations: 2     Fields:    Translation:Humans
    120. Moy B, Polite BN, Halpern MT, Stranne SK, Winer EP, Wollins DS, Newman LA. American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol. 2011 Oct 01; 29(28):3816-24. PMID: 21810680.
      Citations: 70     Fields:    Translation:Humans
    121. Polite BN, Sing A, Sargent DJ, Grothey A, Berlin J, Kozloff M, Feng S. Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE). Cancer. 2012 Feb 15; 118(4):1083-90. PMID: 21800287.
      Citations: 20     Fields:    Translation:Humans
    122. Sharma MR, Wroblewski K, Polite BN, Knost JA, Wallace JA, Modi S, Sleckman BG, Taber D, Vokes EE, Stadler WM, Kindler HL. Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium. Invest New Drugs. 2012 Jun; 30(3):1211-5. PMID: 21552992; PMCID: PMC4317401.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    123. Catenacci DV, Kozloff M, Kindler HL, Polite B. Personalized colon cancer care in 2010. Semin Oncol. 2011 Apr; 38(2):284-308. PMID: 21421118; PMCID: PMC3065981.
      Citations: 20     Fields:    Translation:HumansCells
    124. de Souza JA, Polite BN, Manning WG, Fendrick AM, Ratain MJ. Value-based insurance design in oncology. Lancet Oncol. 2011 Apr; 12(4):321-3. PMID: 21463832.
      Citations: 3     Fields:    Translation:Humans
    125. Ocean AJ, Polite B, Christos P, Horvath L, Hamilton A, Matulich D, Chen HX, Sparano JA, Kindler HL. Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma. Clin Colorectal Cancer. 2010 Dec; 9(5):290-6. PMID: 21208843; PMCID: PMC3623373.
      Citations: 3     Fields:    Translation:Humans
    126. Mell LK, Jeong JH, Nichols MA, Polite BN, Weichselbaum RR, Chmura SJ. Predictors of competing mortality in early breast cancer. Cancer. 2010 Dec 01; 116(23):5365-73. PMID: 20737562.
      Citations: 14     Fields:    Translation:Humans
    127. Ray M, Polite BN. Triple-negative breast cancers: a view from 10,000 feet. Cancer J. 2010 Jan-Feb; 16(1):17-22. PMID: 20164686.
      Citations: 14     Fields:    Translation:Humans
    128. Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR. Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol. 2010 Jan 01; 28(1):15-20. PMID: 19933920.
      Citations: 53     Fields:    Translation:Humans
    129. Polite BN, Cirrincione C, Fleming GF, Berry DA, Seidman A, Muss H, Norton L, Shapiro C, Bakri K, Marcom K, Lake D, Schwartz JH, Hudis C, Winer EP. Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B. J Clin Oncol. 2008 Jun 01; 26(16):2659-65. PMID: 18509177; PMCID: PMC4830463.
      Citations: 13     Fields:    Translation:Humans
    130. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006 Nov 15; 98(22):1647-54. PMID: 17105987.
      Citations: 143     Fields:    Translation:Humans
    131. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006 May 10; 24(14):2179-87. PMID: 16682737.
      Citations: 80     Fields:    Translation:HumansPHPublic Health
    132. Polite BN, Desai AA, Manchen B, Stadler WM. Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial. Clin Genitourin Cancer. 2006 Mar; 4(4):275-80. PMID: 16729911.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    133. Polite BN, Lamont EB. Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries. Cancer. 2006 Feb 15; 106(4):923-30. PMID: 16411227.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    134. Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am. 2005 Jul; 89(4):771-93. PMID: 15925649.
      Citations: 49     Fields:    Translation:Humans
    135. Dignam JJ, Polite B, Yothers G, Raich P, Colangelo L, O'Connell M, Wolmark N. Effect of body mass index on outcomes in patients with Dukes B and C colon cancer: An analysis of NSABP randomized trials. J Clin Oncol. 2005 Jun; 23(16_suppl):3533. PMID: 27944413.
      Citations:    
    136. Polite BN, Desai AA, Peterson AC, Manchen B, Stadler WM. A phase II study of imatinib mesylate (IM) and interferon-alpha (IFNA) in metastatic renal cell carcinoma (RCC). J Clin Oncol. 2005 Jun; 23(16_suppl):4689. PMID: 27946842.
      Citations:    
    137. Polite BN, Olopade OI. Breast cancer and race: a rising tide does not lift all boats equally. Perspect Biol Med. 2005; 48(1 Suppl):S166-75. PMID: 15842094.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    Polite's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (378)
    Explore
    _
    Co-Authors (72)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _